Jon C. Ogg - Author for 24/7 Wall St.
Lastest Stories by Jon C. Ogg
Economists look closely ahead of each monthly unemployment and payrolls report at hiring trends in the private sector and in small businesses.
Published:
Companies that benefit from the moves in gold are generally the miners, but in reality, every company has its own nuances about how its role plays into gold and silver.
Published:
Tuesday's top analyst upgrades and downgrades included Charter Communications, Clorox, FirstEnergy, Neurocrine Biosciences, RingCentral, Roku, Seagate Technology, Take-Two Interactive Software and...
Published:
All those investors who were buying into the hype that Kodak will be a major player in making materials for generic drugs with a big government loan are being reminded just how chasing news pops in...
Published:
If General Electric can get any momentum going and as its Aviation unit gets back to some form of normality, there could be some hidden leverage that propels it much higher in the coming years.
Published:
Monday's top analyst upgrades and downgrades included AbbVie, DuPont, Etsy, Expedia, Exxon Mobile, Kansas City Southern, Merck, Microsoft, Pinterest, Qualcomm, Visa and Yum! Brands.
Published:
The stock market doesn’t seem to care what day of the week that rumors turn into stock moves, but Fridays are often a very ripe time for good old-fashioned buyout rumors. The market lingo has for...
Published:
Vital Farms was not one of the most publicized IPOs, but it should not have been overlooked at all.
Published:
Big-box retailer At Home Group saw a 33% gain in its shares after earnings. Is this sustainable? Two analysts think they have more room to rise.
Published:
Friday's top analyst upgrades and downgrades included Alexion Pharmaceuticals, Allscripts Healthcare Solutions, Alphabet, Amazon.com, Apple, Baidu, Comcast, Electronic Arts, Ford and Facebook.
Published:
Whether it’s all speculation or day trading, it seems there is no end to seeing major gains in small and micro-cap stocks that have positive announcements around anything to do with testing,...
Published:
Investors have flocked to the dividends of Big Pharma and flocked to the limitless upside of major biotech outfits for years. Valuations are no longer considered high for these two healthcare...
Published:
Even before the recession there had been ongoing woes tied to “peak auto” trends. Then came the COVID-19 pandemic and people stopped buying big ticket items like cars. Ford Motor Company (NYSE:...
Published:
Here are eight stocks surging on earnings and seeing the bulk of the analysts who follow the companies issuing much higher price targets ahead.
Published:
Apache has announced a third consecutive Suriname oil discovery, bringing major interest from analysts and much more upside potential.
Published: